Under the EU MDR, post-market surveillance (PMS) is a critical quality control measure designed to identify risks associated with a device after being used for some time. Post-market clinical follow-up (PMCF) is an important part of a manufacturer’s PMS and is used to:
This whitepaper provides valuable insights and tips to help conduct an effective PMCF study to ensure that better, lower-risk products are being brought to market, reducing unavoidable residual risks to acceptable levels.
September 1, 2021
February 18, 2021
November 23, 2020